
CHD1L - Wikipedia
CHD1L, a DNA helicase, possesses chromatin remodeling activity and interacts with PARP1 /PARylation in regulating pluripotency during developmental reprogramming. The CHD1L …
CHD1L Gene - GeneCards | CHD1L Protein | CHD1L Antibody
2024年12月24日 · CHD1L (Chromodomain Helicase DNA Binding Protein 1 Like) is a Protein Coding gene. Diseases associated with CHD1L include Hemorrhage, Intracerebral and Renal …
Diversity roles of CHD1L in normal cell function and tumorigenesis
CHD1L is a regulator of chromosomal integrity maintenance, DNA repair and transcriptional regulation through its bindings to DNA. By regulating kinds of complex networks, CHD1L has …
CHD1L: a novel oncogene - PMC
CHD1L (chromodomain helicase/ATPase DNA binding protein 1-like gene) or ALC1 (amplified in liver cancer 1) is a newly identified oncogene located at Chr1q21 and it is amplified in many …
CHD1L contributes to cisplatin resistance by upregulating the …
2019年2月4日 · Chromodomain helicase/ATPase DNA binding protein 1-like gene (CHD1L) is a recently identified gene associated with malignant tumor progression and patient...
CHD1L chromodomain helicase DNA binding protein 1 like
CHD1L is now considered to be a novel independent biomarker for progression, prognosis and survival in several solid tumors. [Review] Data indicate that chromodomain helicase/ATPase …
CHD1L is associated with poor survival and promotes the …
Chromodomain helicase/ATPase DNA-binding protein 1-like gene (CHD1L) is a new oncogene which has been confirmed to be crucial to the progression of many solid tumors.
Targeting ATP catalytic activity of chromodomain helicase CHD1L …
2024年11月1日 · Our findings establish the lead compound C071–0684 as a potent anticancer agent with a novel molecular backbone, demonstrating remarkable efficacy against colorectal …
CHD1L: a novel oncogene - PMC - National Center for …
2013年12月21日 · CHD1L (chromodomain helicase/ATPase DNA binding protein 1-like gene) or ALC1 (amplified in liver cancer 1) is a newly identified oncogene located at Chr1q21 and it is …
The validation of new CHD1L inhibitors as a therapeutic strategy …
2024年1月1日 · CHD1L expression is indicative of poor outcomes and low survival in cancer patients with various cancer types. Herein, we report a set of CHD1L inhibitors (CHD1Li) …
- 某些结果已被删除